About CastiaRx
CastiaRx is a Financial Services company based in Springfield (United States) founded in 2018, and was acquired by Diplomat in November 2017. Independent Pharmacy Benefit Manager. Its chief executive, as recorded, is Albert Thigpen. Its focus areas include Services for Health Insurers and Healthcare.
Company details
CastiaRx was founded in 2018 and is headquartered in Springfield, United States. Operations are focused on the pharmacy benefit management sector, where independent services are delivered to control prescription drug costs and improve access for clients. Leadership is provided by CEO and President Albert Thigpen. The company functions without affiliation to larger insurers, emphasizing transparent benefit administration across various employer and health plan needs.
- Headquarters Springfield, United States
- Stage Acquired
- SectorsFinancial Services
- Phone•••• ••••
- Website castiarx.com
- Social LinkedIn
- Acquired by Diplomat (Nov 2017)
- Investors
- Acquired byDiplomat
(Nov 2017)
Investors in CastiaRx
CastiaRx has secured backing from 1 investor. Prominent investors backing the company include Optum Specialty Pharmacy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty pharmacy services are provided for complex medical conditions. | 1975 | diplomatpharmacy.com | Flint, United States |
Investor details for CastiaRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CastiaRx
1 people are tracked at CastiaRx (1 in leadership).
| Name | Role | Group |
|---|---|---|
Albert Thigpen | CEO & President | Leadership |
Complete people profiles for CastiaRx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CastiaRx
2 dated milestones of CastiaRx across 1 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Diplomat.
- Founded CastiaRx is founded.
Top companies in Insurance & Risk Management
3 companies that operate in the same segment as CastiaRx (Insurance & Risk Management) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Investment advisory, insurance distribution, and risk management services are provided. | 1998 | Chicago, Illinois, United States | USD 1.6 B | |||
Financial institution offering insurance & transaction services | 1847 | Jacksonville, United States | USD 500 M | USD 14.51 B | 23,530 | |
Integrated healthcare services and coverage are provided nationwide. | 1945 | United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CastiaRx
CastiaRx was founded in 2018.
CastiaRx is headquartered in Springfield, United States.
Albert Thigpen is the CEO of CastiaRx, as recorded in our data.
CastiaRx was founded in 2018 and is headquartered in Springfield, United States. Operations are focused on the pharmacy benefit management sector, where independent services are delivered to control prescription drug costs and improve access for clients. Leadership is provided by CEO and President Albert Thigpen. The company functions without affiliation to larger insurers, emphasizing transparent benefit administration across various employer and health plan needs.
CastiaRx has 1 investor. Key investors include Optum Specialty Pharmacy.
Yes. CastiaRx was acquired by Diplomat in November 2017.